Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Genetic Analysis
100%
Multi-ethnic
100%
Efavirenz
100%
HIV-positive
100%
People of Color
62%
High Genetic Risk
50%
Single nucleotide Polymorphism
37%
Cytochrome P450 3A4 (CYP3A4)
37%
CYP2A6
37%
Cytochrome P450 2D6 (CYP2D6)
37%
Genetic Risk Score
25%
Treatment Discontinuation
25%
Pharmacogenetics
12%
High Risk
12%
Antiretroviral Therapy
12%
Metabolism
12%
Black Women
12%
ESPRIT
12%
Adverse Drug Reaction
12%
Medication Adherence
12%
Risk Score
12%
Non-associated
12%
Nevirapine
12%
Cox Regression Model
12%
Premature Discontinuation
12%
Virological Failure
12%
Accessory Pathway
12%
Score-based
12%
Atazanavir
12%
Drug Discontinuation
12%
Risk and Time
12%
Viral Suppression
12%
Psychiatric Side Effects
12%
Metabolic Pathways
12%
Pharmacogenetic Testing
12%
Antiretroviral Regimen
12%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Human Immunodeficiency Virus
100%
Efavirenz
100%
Genetic Risk
62%
Single-Nucleotide Polymorphism
37%
CYP2A6
37%
CYP2B6
37%
CYP3A4
37%
Metabolic Pathway
25%
Morbidity
25%
Enzyme
12%
Pharmacogenetics
12%
Accessory Pathway
12%
Pharmacogenetic Testing
12%
Drug Effect
12%
Patient Compliance
12%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Efavirenz
100%
Genetic Risk
62%
CYP2A6
37%
CYP3A4
37%
CYP2B6
37%
Pharmacogenetics
25%
Morbidity
25%
Prematurity
25%
Adverse Drug Reaction
12%
Nevirapine
12%
Atazanavir
12%
Enzymes
12%
Side Effect
12%